Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NexLife vs RxION Health

NexLife
Graded #147

Higher grade

vs+12.100000000000001
RxION Health
Graded #415

Lower grade

The verdict

NexLife takes it — 68.5/100 to 56.4/100.

NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +25
70
45
Dose & formulationNexLife +24
64
40
Clinical oversightNexLife +7
89
82
Labs & monitoringNexLife +1
53
52
FulfillmentRxION Health +4
67
71
Contract termsEven
55
55
NexLife · left barRxION Health · right bar

The numbers

MetricNexLifeRxION Health
WeighScore68.5/10056.4/100
GradeCC
Scorecard rank#147#415
Semaglutide$165/mo (compounded)Not disclosed
Tirzepatide$215/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
NexLife

Graded #147 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
RxION Health

Graded #415 · C

Strengths

  • LegitScript Certified
  • Offers both semaglutide and tirzepatide, including microdosing
  • HIPAA compliant
  • States its medications are FDA-regulated

Where it loses points

  • No physical address listed
  • No named pharmacy partners
  • Not available to residents of New Jersey, Alaska, or Mississippi

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard